Table 3. Characteristics and oncological outcomes between VATS and open surgery approach.
| Variables | Total (n=152) | VATS (n=29) | Open (n=123) | P |
|---|---|---|---|---|
| Charlson index | 1.74±1.55 | 1.92±1.83 | 1.70±1.48 | 0.728 |
| Complications | 32 (21.1%) | 4 (13.8%) | 28 (22.8%) | 0.447 |
| Masaoka | ||||
| Masaoka (I–II) | 111 (73.0%) | 28 (96.6%) | 83 (67.5%) | 0.001 |
| Masaoka (III–IV) | 41 (27.0%) | 1 (3.4%) | 40 (32.5%) | 0.001 |
| WHO (thymoma) | 135 (88.8%) | 28 (96.6%) | 107 (87.0%) | 0.197 |
| CT neo | 17 (11.2%) | 0 | 17 (13.8%) | 0.044 |
| MG | 21 (13.8%) | 7 (24.1%) | 14 (11.4%) | 0.129 |
| Overall (5 years) | 87.5% | 92.5% | 86.3% | 0.959 |
| Disease-free (5 years) | 90.8% | 96.0% | 89.4% | 0.459 |
| Masaoka (stage I–II) | N=111 | N=28 | N=83 | – |
| Overall (5 years) | 89.8% | 92.2% | 89.0% | 0.406 |
| Disease-free (5 years) | 96.5% | 95.8% | 96.7% | 0.603 |
MG, myasthenia gravis; WHO, World Health Organization; VATS, video-assisted thoracic surgery.